Stocks | |||||
The table gives an overview of all stocks, alphabetically sorted. | |||||
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z |
Name | Symbol | Analysis date | Close | +/- % |
Regional Management | RM | Jun 11, 2024 | 28.04 | -0.64 |
Regions Financial | RF | Jun 11, 2024 | 18.19 | 0.00 |
Regions Financial B Pref | RF-B | Jun 11, 2024 | 24.97 | -0.06 |
Regions Financial C Pref | RF-C | Jun 11, 2024 | 22.49 | 0.00 |
Regions Financial E Pref | RF-E | Jun 11, 2024 | 17.48 | -1.02 |
Regis | RGS | Jun 11, 2024 | 4.58 | +4.33 |
Regulus Therapeutics | RGLS | Jun 11, 2024 | 2.42 | -1.43 |
Reinsurance Group of America | RGA | Jun 11, 2024 | 201.32 | -1.56 |
REIT Index ETF Vanguard | VNQ | Jun 11, 2024 | 82.94 | -0.36 |
Rekor Systems | REKR | Jun 11, 2024 | 1.56 | -1.27 |
Relay Therapeutics | RLAY | Jun 11, 2024 | 7.23 | -3.98 |
Reliance | RS | Jun 11, 2024 | 280.79 | -1.33 |
Reliance Global | RELI | Jun 11, 2024 | 0.23 | -0.30 |
Relmada Therapeutics | RLMD | Jun 11, 2024 | 3.04 | -2.56 |
RELX ADR | RELX | Jun 11, 2024 | 44.56 | -0.49 |
Renaissance Ipo ETF | IPO | Jun 11, 2024 | 39.59 | -0.63 |
RenaissanceRe | RNR | Jun 11, 2024 | 223.29 | -2.05 |
RenaissanceRe G Pref | RNR-G | Jun 11, 2024 | 17.18 | -1.26 |
RenaissanceRe Holding F Pref | RNR-F | Jun 11, 2024 | 22.73 | +0.04 |
Renalytix ADR | RNLX | Jun 11, 2024 | 0.47 | +1.39 |
Renasant | RNST | Jun 11, 2024 | 28.30 | -0.67 |
Reneo Pharmaceuticals | RPHM | Jun 11, 2024 | 1.71 | +1.79 |
ReNew Energy Global A Shares | RNW | Jun 11, 2024 | 6.52 | +0.31 |
Renn Fund | RCG | Jun 11, 2024 | 1.71 | +0.01 |
Renovaro Biosciences | RENB | Jun 11, 2024 | 1.46 | -2.01 |
RenovoRx | RNXT | Jun 11, 2024 | 1.05 | +1.94 |
Rent The Runway A | RENT | Jun 11, 2024 | 25.95 | +1.92 |
Rentokil Initial ADR | RTO | Jun 11, 2024 | 26.92 | +1.20 |
Repare Therapeutics | RPTX | Jun 11, 2024 | 3.80 | -5.00 |
Repay A | RPAY | Jun 11, 2024 | 10.87 | +1.59 |
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.